vs
Apple Hospitality REIT, Inc.（APLE）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是Apple Hospitality REIT, Inc.的1.7倍（$540.7M vs $326.4M），Apple Hospitality REIT, Inc.净利率更高（9.1% vs -2.9%，领先12.0%），Apple Hospitality REIT, Inc.同比增速更快（-2.0% vs -14.1%），Apple Hospitality REIT, Inc.自由现金流更多（$282.0M vs $36.0M），过去两年Apple Hospitality REIT, Inc.的营收复合增速更高（-0.5% vs -2.3%）
莱曼 hospitality properties是一家深耕酒店、度假村、娱乐及媒体领域的企业，得名于旗下核心资产——位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾作为爱德华·盖洛德旗下俄克拉荷马出版公司子公司的时期，1983年收购WSM公司后，拿下大奥普里等知名IP，奠定了如今的业务发展基础。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
APLE vs ICUI — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $326.4M | $540.7M |
| 净利润 | $29.6M | $-15.7M |
| 毛利率 | 37.2% | 37.5% |
| 营业利润率 | 15.2% | 1.0% |
| 净利率 | 9.1% | -2.9% |
| 营收同比 | -2.0% | -14.1% |
| 净利润同比 | -0.7% | 34.0% |
| 每股收益（稀释后） | $0.13 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $326.4M | $540.7M | ||
| Q3 25 | $373.9M | $537.0M | ||
| Q2 25 | $384.4M | $548.9M | ||
| Q1 25 | $327.7M | $604.7M | ||
| Q4 24 | $333.0M | $629.8M | ||
| Q3 24 | $378.8M | $589.1M | ||
| Q2 24 | $390.1M | $596.5M | ||
| Q1 24 | $329.5M | $566.7M |
| Q4 25 | $29.6M | $-15.7M | ||
| Q3 25 | $50.9M | $-3.4M | ||
| Q2 25 | $63.6M | $35.3M | ||
| Q1 25 | $31.2M | $-15.5M | ||
| Q4 24 | $29.8M | $-23.8M | ||
| Q3 24 | $56.3M | $-33.0M | ||
| Q2 24 | $73.9M | $-21.4M | ||
| Q1 24 | $54.0M | $-39.5M |
| Q4 25 | 37.2% | 37.5% | ||
| Q3 25 | 40.6% | 37.4% | ||
| Q2 25 | 42.6% | 37.9% | ||
| Q1 25 | 39.0% | 34.7% | ||
| Q4 24 | 38.6% | 36.1% | ||
| Q3 24 | 41.9% | 34.8% | ||
| Q2 24 | 44.6% | 34.8% | ||
| Q1 24 | 40.1% | 32.7% |
| Q4 25 | 15.2% | 1.0% | ||
| Q3 25 | 19.4% | 2.6% | ||
| Q2 25 | 22.1% | 1.9% | ||
| Q1 25 | 15.5% | 2.1% | ||
| Q4 24 | 15.0% | 6.0% | ||
| Q3 24 | 20.5% | 1.4% | ||
| Q2 24 | 24.0% | 1.3% | ||
| Q1 24 | 21.7% | -1.9% |
| Q4 25 | 9.1% | -2.9% | ||
| Q3 25 | 13.6% | -0.6% | ||
| Q2 25 | 16.6% | 6.4% | ||
| Q1 25 | 9.5% | -2.6% | ||
| Q4 24 | 9.0% | -3.8% | ||
| Q3 24 | 14.9% | -5.6% | ||
| Q2 24 | 19.0% | -3.6% | ||
| Q1 24 | 16.4% | -7.0% |
| Q4 25 | $0.13 | $-0.63 | ||
| Q3 25 | $0.21 | $-0.14 | ||
| Q2 25 | $0.27 | $1.43 | ||
| Q1 25 | $0.13 | $-0.63 | ||
| Q4 24 | $0.13 | $-0.97 | ||
| Q3 24 | $0.23 | $-1.35 | ||
| Q2 24 | $0.31 | $-0.88 | ||
| Q1 24 | $0.22 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.5M | — |
| 总债务越低越好 | $1.5B | — |
| 股东权益账面价值 | $3.1B | $2.1B |
| 总资产 | $4.9B | $4.1B |
| 负债/权益比越低杠杆越低 | 0.49× | — |
8季度趋势，按日历期对齐
| Q4 25 | $8.5M | — | ||
| Q3 25 | $50.3M | — | ||
| Q2 25 | $7.9M | — | ||
| Q1 25 | $14.9M | — | ||
| Q4 24 | $10.3M | $308.6M | ||
| Q3 24 | $6.1M | $312.5M | ||
| Q2 24 | $7.2M | $302.6M | ||
| Q1 24 | $4.9M | $251.4M |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $3.1B | $2.1B | ||
| Q3 25 | $3.2B | $2.1B | ||
| Q2 25 | $3.2B | $2.1B | ||
| Q1 25 | $3.2B | $2.0B | ||
| Q4 24 | $3.3B | $2.0B | ||
| Q3 24 | $3.3B | $2.0B | ||
| Q2 24 | $3.3B | $2.0B | ||
| Q1 24 | $3.3B | $2.1B |
| Q4 25 | $4.9B | $4.1B | ||
| Q3 25 | $4.9B | $4.1B | ||
| Q2 25 | $4.9B | $4.1B | ||
| Q1 25 | $4.9B | $4.2B | ||
| Q4 24 | $5.0B | $4.2B | ||
| Q3 24 | $5.0B | $4.3B | ||
| Q2 24 | $5.1B | $4.3B | ||
| Q1 24 | $5.0B | $4.3B |
| Q4 25 | 0.49× | — | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | 0.46× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.45× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $370.2M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | $282.0M | $36.0M |
| 自由现金流率自由现金流/营收 | 86.4% | 6.6% |
| 资本支出强度资本支出/营收 | 27.0% | 4.6% |
| 现金转化率经营现金流/净利润 | 12.50× | — |
| 过去12个月自由现金流最近4个季度 | $516.8M | $91.8M |
8季度趋势，按日历期对齐
| Q4 25 | $370.2M | $60.6M | ||
| Q3 25 | $126.4M | $56.7M | ||
| Q2 25 | $108.8M | $11.2M | ||
| Q1 25 | $49.1M | $51.3M | ||
| Q4 24 | $405.4M | $40.2M | ||
| Q3 24 | $128.2M | $36.1M | ||
| Q2 24 | $127.3M | $82.0M | ||
| Q1 24 | $54.7M | $45.8M |
| Q4 25 | $282.0M | $36.0M | ||
| Q3 25 | $109.0M | $27.6M | ||
| Q2 25 | $96.2M | $-8.5M | ||
| Q1 25 | $29.5M | $36.7M | ||
| Q4 24 | $327.1M | $16.1M | ||
| Q3 24 | $113.1M | $16.2M | ||
| Q2 24 | $115.0M | $62.5M | ||
| Q1 24 | $34.4M | $29.9M |
| Q4 25 | 86.4% | 6.6% | ||
| Q3 25 | 29.2% | 5.1% | ||
| Q2 25 | 25.0% | -1.5% | ||
| Q1 25 | 9.0% | 6.1% | ||
| Q4 24 | 98.2% | 2.6% | ||
| Q3 24 | 29.9% | 2.7% | ||
| Q2 24 | 29.5% | 10.5% | ||
| Q1 24 | 10.4% | 5.3% |
| Q4 25 | 27.0% | 4.6% | ||
| Q3 25 | 4.7% | 5.4% | ||
| Q2 25 | 3.3% | 3.6% | ||
| Q1 25 | 6.0% | 2.4% | ||
| Q4 24 | 23.5% | 3.8% | ||
| Q3 24 | 4.0% | 3.4% | ||
| Q2 24 | 3.2% | 3.3% | ||
| Q1 24 | 6.2% | 2.8% |
| Q4 25 | 12.50× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 1.71× | 0.32× | ||
| Q1 25 | 1.57× | — | ||
| Q4 24 | 13.59× | — | ||
| Q3 24 | 2.28× | — | ||
| Q2 24 | 1.72× | — | ||
| Q1 24 | 1.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLE
| Occupancy | $293.0M | 90% |
| Hotel Other | $17.2M | 5% |
| Food And Beverage | $16.3M | 5% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
